INVESTOR PROFILE
Joyance Partners
Founded in 2012 in San Francisco, Joyance invests in the “vectors of happiness” that it classifies as areas of science, including genetics and bioscience, the microbiome, neuroscience, virtual and augmented reality, and foodtech. It also invests in the area of social networking. Its investments are made through its management company, Ataraxia, and many have a European focus. It currently has 115 companies in its portfolio, with recent investments including in the August 2021 $3.6m seed round of Polish bionic limb manufacturer and in the July 2021 $8m Series A round of Israeli sports injury AI platform Zone7.
